AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 70 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.08 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $25,000 | +66.7% | 1,112 | +81.7% | 0.01% | +33.3% |
Q4 2018 | $15,000 | +400.0% | 612 | +446.4% | 0.01% | +500.0% |
Q3 2018 | $3,000 | -25.0% | 112 | -15.2% | 0.00% | -50.0% |
Q2 2018 | $4,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $4,000 | -69.2% | 132 | -62.1% | 0.00% | -66.7% |
Q4 2017 | $13,000 | +44.4% | 348 | 0.0% | 0.01% | +50.0% |
Q3 2017 | $9,000 | +28.6% | 348 | -2.2% | 0.00% | 0.0% |
Q2 2017 | $7,000 | -12.5% | 356 | -0.3% | 0.00% | 0.0% |
Q1 2017 | $8,000 | +14.3% | 357 | +1.4% | 0.00% | +33.3% |
Q4 2016 | $7,000 | +16.7% | 352 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $6,000 | +20.0% | 352 | -9.7% | 0.00% | 0.0% |
Q2 2016 | $5,000 | -16.7% | 390 | 0.0% | 0.00% | -20.0% |
Q1 2016 | $6,000 | – | 390 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |